+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Dermal Fillers Market Size, Share & Industry Trends Analysis Report By Type, By Product, By End-use (MedSpa, Cosmetic Surgery Clinics and Hospitals), By Application, By Country and Growth Forecast, 2023-2029

  • PDF Icon

    Report

  • 90 Pages
  • April 2023
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5806394
The Asia Pacific Dermal Fillers Market should witness market growth of 9.1% CAGR during the forecast period (2023-2029).

Due to new developments in rejuvenation and aesthetic enhancements that were previously only possible through surgery, dermal fillers have recently seen a sharp increase in popularity. Dermal fillers exhibit immediate benefits in aesthetic volume replacement treatments due to their less invasive nature. Some market participants are working on cutting-edge technology, new items, and some are already in the pipeline. New advanced products have been developed to accelerate the market expansion for dermal fillers.

Due to the explosion of social media, factors such as the benefit of product comparison, an increase in the desire to keep young looks, and an uptick in the anti-aging craze all contribute to the market's expansion. Under the eyes, tear trough filler is an injectable procedure. It serves to accentuate the volume under the eyelids. Although other substances might be employed, hyaluronic acid is often the main component of the product most frequently used in this area.

China's demand for medical tourism is expected to surge in the coming years. The rapid expansion of China's economy, which is now one of the largest in the world, has enhanced its reputation as a nation with a cutting-edge healthcare system. This has substantially increased China's medical tourism industry. Government support has also significantly impacted the country's dental tourism growth. It is anticipated that the expanding healthcare infrastructure and elite medical personnel will encourage more individuals to choose to get aesthetic surgeries in this region, boosting the market growth in Asia Pacific.

The China market dominated the Asia Pacific Dermal Fillers Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $779.5 million by 2029. The Japan market is estimated to grow a CAGR of 8.4% during (2023-2029). Additionally, The India market would experience a CAGR of 9.8% during (2023-2029).

Based on Type, the market is segmented into Biodegradable and Non-biodegradable. Based on Product, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid (PLLA), Polymethyl-methacrylate Microspheres and Others. Based on End-use, the market is segmented into MedSpa, Cosmetic Surgery Clinics and Hospitals. Based on Application, the market is segmented into Wrinkle Correction, Lip Enhancement, Facial Contouring, Scar Treatment and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.

Scope of the Study

By Type

  • Biodegradable
  • Non-biodegradable

By Product

  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Polylactic Acid (PLLA)
  • Polymethyl-methacrylate Microspheres
  • Others

By End-use

  • MedSpa
  • Cosmetic Surgery Clinics
  • Hospitals

By Application

  • Wrinkle Correction
  • Lip Enhancement
  • Facial Contouring
  • Scar Treatment
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Bioplus Co. Ltd
  • Bioxis pharmaceuticals
  • Suneva Medical, Inc.
  • Galderma S.A.
  • Allergan PLC (AbbVie, Inc.)
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • Revance Therapeutics, Inc.
  • Medytox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Prollenium Medical Technologies Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Dermal Fillers Market, by Type
1.4.2 Asia Pacific Dermal Fillers Market, by Product
1.4.3 Asia Pacific Dermal Fillers Market, by End-use
1.4.4 Asia Pacific Dermal Fillers Market, by Application
1.4.5 Asia Pacific Dermal Fillers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Dermal Fillers Market
Chapter 4. Asia Pacific Dermal Fillers Market by Type
4.1 Asia Pacific Biodegradable Market by Country
4.2 Asia Pacific Non-biodegradable Market by Country
Chapter 5. Asia Pacific Dermal Fillers Market by Product
5.1 Asia Pacific Hyaluronic Acid Market by Country
5.2 Asia Pacific Calcium Hydroxylapatite Market by Country
5.3 Asia Pacific Polylactic Acid (PLLA) Market by Country
5.4 Asia Pacific Polymethyl-methacrylate Microspheres Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Dermal Fillers Market by End-use
6.1 Asia Pacific MedSpa Market by Country
6.2 Asia Pacific Cosmetic Surgery Clinics Market by Country
6.3 Asia Pacific Hospitals Market by Country
Chapter 7. Asia Pacific Dermal Fillers Market by Application
7.1 Asia Pacific Wrinkle Correction Market by Country
7.2 Asia Pacific Lip Enhancement Market by Country
7.3 Asia Pacific Facial Contouring Market by Country
7.4 Asia Pacific Scar Treatment Market by Country
7.5 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Dermal Fillers Market by Country
8.1 China Dermal Fillers Market
8.1.1 China Dermal Fillers Market by Type
8.1.2 China Dermal Fillers Market by Product
8.1.3 China Dermal Fillers Market by End-use
8.1.4 China Dermal Fillers Market by Application
8.2 Japan Dermal Fillers Market
8.2.1 Japan Dermal Fillers Market by Type
8.2.2 Japan Dermal Fillers Market by Product
8.2.3 Japan Dermal Fillers Market by End-use
8.2.4 Japan Dermal Fillers Market by Application
8.3 India Dermal Fillers Market
8.3.1 India Dermal Fillers Market by Type
8.3.2 India Dermal Fillers Market by Product
8.3.3 India Dermal Fillers Market by End-use
8.3.4 India Dermal Fillers Market by Application
8.4 South Korea Dermal Fillers Market
8.4.1 South Korea Dermal Fillers Market by Type
8.4.2 South Korea Dermal Fillers Market by Product
8.4.3 South Korea Dermal Fillers Market by End-use
8.4.4 South Korea Dermal Fillers Market by Application
8.5 Singapore Dermal Fillers Market
8.5.1 Singapore Dermal Fillers Market by Type
8.5.2 Singapore Dermal Fillers Market by Product
8.5.3 Singapore Dermal Fillers Market by End-use
8.5.4 Singapore Dermal Fillers Market by Application
8.6 Malaysia Dermal Fillers Market
8.6.1 Malaysia Dermal Fillers Market by Type
8.6.2 Malaysia Dermal Fillers Market by Product
8.6.3 Malaysia Dermal Fillers Market by End-use
8.6.4 Malaysia Dermal Fillers Market by Application
8.7 Rest of Asia Pacific Dermal Fillers Market
8.7.1 Rest of Asia Pacific Dermal Fillers Market by Type
8.7.2 Rest of Asia Pacific Dermal Fillers Market by Product
8.7.3 Rest of Asia Pacific Dermal Fillers Market by End-use
8.7.4 Rest of Asia Pacific Dermal Fillers Market by Application
Chapter 9. Company Profiles
9.1 Bioplus Co. Ltd
9.1.1 Company Overview
9.2 Bioxis pharmaceuticals
9.2.1 Company Overview
9.3 Suneva Medical, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Partnerships, Collaborations, and Agreements:
9.4 Galderma S.A.
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.2.2 Product Launches and Product Expansions:
9.4.2.3 Acquisition and Mergers:
9.5 Allergan PLC (AbbVie, Inc.)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Product Launches and Product Expansions:
9.7 Revance Therapeutics, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Trials and Approvals:
9.8 Medytox Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Trials and Approvals:
9.9 Merz Pharma GmbH & Co. KGaA
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.9.2.2 Geographical Expansions:
9.10. Prollenium Medical Technologies Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Acquisition and Mergers:

Companies Mentioned

  • Bioplus Co. Ltd
  • Bioxis pharmaceuticals
  • Suneva Medical, Inc.
  • Galderma S.A.
  • Allergan PLC (AbbVie, Inc.)
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • Revance Therapeutics, Inc.
  • Medytox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Prollenium Medical Technologies Inc.

Methodology

Loading
LOADING...